BLACKROCK SCIENCE & TECH TR (BST) Fundamental Analysis & Valuation

NYSE:BST • US09258G1040

Current stock price

37.24 USD
+0.03 (+0.08%)
At close:
37.44 USD
+0.2 (+0.54%)
After Hours:

This BST fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. BST Profitability Analysis

1.1 Basic Checks

  • In the past year BST was profitable.
  • In the past year BST had a positive cash flow from operations.
  • Of the past 5 years BST 4 years were profitable.
  • Of the past 5 years BST 4 years had a positive operating cash flow.
BST Yearly Net Income VS EBIT VS OCF VS FCFBST Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M -400M -600M

1.2 Ratios

Industry RankSector Rank
ROA 16.87%
ROE 16.96%
ROIC N/A
ROA(3y)20.07%
ROA(5y)0.11%
ROE(3y)20.33%
ROE(5y)0.18%
ROIC(3y)N/A
ROIC(5y)N/A
BST Yearly ROA, ROE, ROICBST Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 -60

1.3 Margins

  • In the last couple of years the Profit Margin of BST has declined.
  • The Operating Margin and Gross Margin are not available for BST so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 5070.71%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y-24.87%
GM growth 3YN/A
GM growth 5YN/A
BST Yearly Profit, Operating, Gross MarginsBST Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10K -10K 20K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. BST Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, BST has about the same amount of shares outstanding.
  • The number of shares outstanding for BST has been increased compared to 5 years ago.
  • The debt/assets ratio for BST is higher compared to a year ago.
BST Yearly Shares OutstandingBST Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
BST Yearly Total Debt VS Total AssetsBST Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

  • BST has an Altman-Z score of 93.18. This indicates that BST is financially healthy and has little risk of bankruptcy at the moment.
  • The Debt to FCF ratio of BST is 0.01, which is an excellent value as it means it would take BST, only 0.01 years of fcf income to pay off all of its debts.
  • BST has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
  • Even though the debt/equity ratio score it not favorable for BST, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Altman-Z 93.18
ROIC/WACCN/A
WACCN/A
BST Yearly LT Debt VS Equity VS FCFBST Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B

2.3 Liquidity

  • A Current Ratio of 0.05 indicates that BST may have some problems paying its short term obligations.
  • BST has a Quick Ratio of 0.05. This is a bad value and indicates that BST is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.05
Quick Ratio 0.05
BST Yearly Current Assets VS Current LiabilitesBST Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. BST Growth Analysis

3.1 Past

  • BST shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -8.21%.
  • Measured over the past years, BST shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -19.03% on average per year.
  • Looking at the last year, BST shows a quite strong growth in Revenue. The Revenue has grown by 17.86% in the last year.
  • Measured over the past years, BST shows a quite strong growth in Revenue. The Revenue has been growing by 15.01% on average per year.
EPS 1Y (TTM)-8.21%
EPS 3YN/A
EPS 5Y-19.03%
EPS Q2Q%110%
Revenue 1Y (TTM)17.86%
Revenue growth 3Y6.22%
Revenue growth 5Y15.01%
Sales Q2Q%-10.93%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BST Yearly Revenue VS EstimatesBST Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1M 2M 3M 4M

More info and screens

Find the best growth stocksShow best growing peers

2

4. BST Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 5.20, the valuation of BST can be described as very cheap.
  • BST's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 25.54.
Industry RankSector Rank
PE 5.2
Fwd PE N/A
BST Price Earnings VS Forward Price EarningsBST Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 9.04
EV/EBITDA N/A
BST Per share dataBST EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. BST Dividend Analysis

5.1 Amount

  • BST has a Yearly Dividend Yield of 10.62%, which is a nice return.
  • Compared to an average S&P500 Dividend Yield of 1.89, BST pays a better dividend.
Industry RankSector Rank
Dividend Yield 10.62%

5.2 History

  • On average, the dividend of BST grows each year by 16.07%, which is quite nice.
  • BST has been paying a dividend for at least 10 years, so it has a reliable track record.
  • BST has decreased its dividend in the last 3 years.
Dividend Growth(5Y)16.07%
Div Incr Years0
Div Non Decr Years2
BST Yearly Dividends per shareBST Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3 4

5.3 Sustainability

  • 56.97% of the earnings are spent on dividend by BST. This is a bit on the high side, but may be sustainable.
  • BST's earnings are declining while the Dividend Rate has been growing. This means the dividend growth is most likely not sustainable.
DP56.97%
EPS Next 2YN/A
EPS Next 3YN/A
BST Yearly Income VS Free CF VS DividendBST Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M -400M -600M
BST Dividend Payout.BST Dividend Payout, showing the Payout Ratio.BST Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

BST Fundamentals: All Metrics, Ratios and Statistics

BLACKROCK SCIENCE & TECH TR

NYSE:BST (3/23/2026, 7:37:47 PM)

After market: 37.44 +0.2 (+0.54%)

37.24

+0.03 (+0.08%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)03-05
Earnings (Next)N/A
Inst Owners20.12%
Inst Owner Change3.77%
Ins Owners0%
Ins Owner Change47.4%
Market Cap1.29B
Revenue(TTM)4.95M
Net Income(TTM)251.00M
Analysts0
Price TargetN/A
Short Float %0.05%
Short Ratio0.18
Dividend
Industry RankSector Rank
Dividend Yield 10.62%
Yearly Dividend4.09
Dividend Growth(5Y)16.07%
DP56.97%
Div Incr Years0
Div Non Decr Years2
Ex-Date06-15
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 5.2
Fwd PE N/A
P/S 261.21
P/FCF 9.04
P/OCF 9.04
P/B 0.87
P/tB 0.87
EV/EBITDA N/A
EPS(TTM)7.16
EY19.23%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)4.12
FCFY11.06%
OCF(TTM)4.12
OCFY11.06%
SpS0.14
BVpS42.62
TBVpS42.62
PEG (NY)N/A
PEG (5Y)N/A
Graham Number82.86
Profitability
Industry RankSector Rank
ROA 16.87%
ROE 16.96%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 5070.71%
GM N/A
FCFM 2888.89%
ROA(3y)20.07%
ROA(5y)0.11%
ROE(3y)20.33%
ROE(5y)0.18%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y-24.87%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 56.97%
Current Ratio 0.05
Quick Ratio 0.05
Altman-Z 93.18
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)36.49%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-8.21%
EPS 3YN/A
EPS 5Y-19.03%
EPS Q2Q%110%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)17.86%
Revenue growth 3Y6.22%
Revenue growth 5Y15.01%
Sales Q2Q%-10.93%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-8.92%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y52.13%
FCF growth 3Y27.09%
FCF growth 5YN/A
OCF growth 1Y52.13%
OCF growth 3Y27.09%
OCF growth 5YN/A

BLACKROCK SCIENCE & TECH TR / BST Fundamental Analysis FAQ

What is the ChartMill fundamental rating of BLACKROCK SCIENCE & TECH TR (BST) stock?

ChartMill assigns a fundamental rating of 3 / 10 to BST.


What is the valuation status of BLACKROCK SCIENCE & TECH TR (BST) stock?

ChartMill assigns a valuation rating of 2 / 10 to BLACKROCK SCIENCE & TECH TR (BST). This can be considered as Overvalued.


Can you provide the profitability details for BLACKROCK SCIENCE & TECH TR?

BLACKROCK SCIENCE & TECH TR (BST) has a profitability rating of 2 / 10.


What is the valuation of BLACKROCK SCIENCE & TECH TR based on its PE and PB ratios?

The Price/Earnings (PE) ratio for BLACKROCK SCIENCE & TECH TR (BST) is 5.2 and the Price/Book (PB) ratio is 0.87.


How financially healthy is BLACKROCK SCIENCE & TECH TR?

The financial health rating of BLACKROCK SCIENCE & TECH TR (BST) is 3 / 10.